Cite
HARVARD Citation
Louis, E. et al. (2023). Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. Lancet gastroenterology and hepatology. pp. 215-227. [Online].